Emergency Medicine · Medical Literature
Conservative Oxygen for Unresponsive Patients after Cardiac Arrest
Abstract
New England Journal of Medicine, Ahead of Print.
Clinical relevance
In unresponsive adults receiving mechanical ventilation in the ICU after cardiac arrest, does a conservative oxygen strategy (targeting SpO₂ 90–95%, FiO₂ titrated down to 0.21) improve 180-day survival with favorable functional outcome compared with a liberal oxygen strategy (no upper SpO₂ limit, minimum FiO₂ 0.30)? __SNAPSHOT__ {"studyDesign":"Investigator-initiated, parallel-group, open-label, assessor-blinded randomized controlled trial (LOGICAL trial)","setting":"53 ICUs across Australia (39 sites), New Zealand (13 sites), and Ireland (1 site); enrollment September 2021 – June 2024","sampleSize":"n=1,840 enrolled; 19 withdrew consent; primary outcome data available for n=1,709 (conservative: n=819 [93.8%], liberal: n=890 [93.9%]); randomized conservative n=882, liberal n=958","population":"Unresponsive adults receiving mechanical ventilation in the ICU after resuscitation from cardiac arrest, with suspected hypoxic-ischemic encephalopathy (HIE). Mean age 60 years; 29% women. Majority had out-of-hospital cardiac arrest (most witnessed); bystander CPR rate ~78%; median time to ROSC 25.5 minutes; median time from ROSC to randomization ~7 hours.","intervention":"Conservative oxygen therapy: upper SpO₂ alarm set at 95%, FiO₂ decreased to 0.21 provided SpO₂ remained above the lower limit of 90%; supplemental oxygen discontinued after extubation if SpO₂ was above the lower limit","comparator":"Liberal oxygen therapy: no upper SpO₂ limit restriction; minimum FiO₂ during mechanical ventilation set at 0.30; default lower SpO₂ limit of 90% maintained (same as conservative group). Clinician-directed FiO₂ increases were permitted in both arms for ICU procedures (e.g., bronchoscopy, suctioning, tracheostomy).","primaryOutcome":"Survival with a favorable functional outcome at 180 days post-randomization, defined as an Extended Glasgow Outcome Scale (GOS-E) score of 5–8 (lower moderate disability to good recovery); GOS-E 1–4 was classified as unfavorable","followUp":"180 days post-randomization","fundingSource":"Government/non-profit: Health Research Council of New Zealand, Alpha Charitable Trust, David and Cassie Anderson Medical Charitable Trust (New Zealand), National Health and Medical Research Council (Australia), and the Irish Critical Care Clinical Trials Network. No industry funding reported."}
Key findings
The primary outcome of survival with favorable functional status (GOS-E 5–8) at 180 days was achieved in 38.2% of patients in the conservative-oxygen group versus 39.7% in the liberal-oxygen group (absolute difference: −1.5 percentage points [calculated]; p=0.65). The difference was not statistically significant. Secondary outcomes of quality of life and cognition were also not significantly different between groups. No treatment-related adverse events were reported. Prespecified subgroup analyses, including stratification by time from ROSC to randomization (≤4 hours vs. later) and time from ICU admission to randomization (≤2 hours vs. later), showed no differential treatment effect. The NNT is not calculable given the absence of benefit. The trial was not blinded at the clinical level (open-label), though outcome assessment was blinded.
Practice implications
⚠️ Only the abstract and secondary reporting are available; the full dataset, prespecified analysis plan, and supplementary outcomes have not been independently reviewed. The LOGICAL trial is a large, adequately powered, pragmatic RCT that provides strong evidence against a clinical benefit of conservative oxygen targeting (SpO₂ 90–95%, FiO₂ to 0.21) compared with liberal oxygenation in mechanically ventilated, unresponsive post-cardiac arrest ICU patients. The study was powered for a clinically meaningful improvement and returned a convincingly neutral result (p=0.65), suggesting the absence of a meaningful treatment effect rather than simply inadequate power. The hypothesis — grounded in animal data and a post-hoc ICU-ROX subgroup analysis suggesting potential benefit of conservative oxygen in HIE — was not confirmed in this definitive trial. Results align with earlier neutral findings from the BOX oxygen trial and the EXACT trial in out-of-hospital cardiac arrest. The trial enrolled a representative post-cardiac arrest ICU population, but was limited to well-resourced health systems in Australia, New Zealand, and Ireland, potentially limiting generalizability to lower-resource settings or populations with markedly different arrest characteristics. Patients with different ROSC times, cardiac arrest etiologies, or varying pre-hospital oxygen exposures may not be equally represented. Importantly, the conservative arm achieved meaningful separation in FiO₂ delivery, suggesting the negative result reflects a true absence of benefit rather than a protocol failure. No safety signal was identified with conservative oxygen. Current practice does not need to shift toward aggressive oxygen restriction in this population, and the rationale for routine hyperoxia avoidance in critically ill patients more broadly remains intact but does not require a specific low-target protocol in post-arrest HIE. __LIMITATIONS__ Open-label design: treating clinicians were not blinded to group allocation, introducing potential for co-intervention bias, though outcome assessors were blinded.,Protocol deviations in achieving oxygen targets were noted, though sensitivity analyses excluding deviating patients were reported as robust.,Clinician-directed FiO₂ increases were permitted in both arms for ICU procedures, potentially narrowing the real-world oxygen exposure difference between groups.,More patients were assigned to the liberal oxygen group (n=958 vs. 882) despite adaptive randomization not favoring this at any point — the basis and impact of this imbalance requires review of the full manuscript.,Median time from ROSC to randomization was approximately 7 hours; whether earlier intervention (within the first 1–2 hours post-ROSC) would yield different results remains unanswered, though subgroup analysis up to 4 hours from ROSC was also neutral.,Generalizability is limited to well-resourced ICU settings in Australia, New Zealand, and Ireland — applicability to other healthcare systems is uncertain.,The LOGICAL trial is nested within the larger Mega-ROX HIE trial; how co-enrollment and shared infrastructure may have influenced results is not assessable from the abstract alone.,Only the abstract is available for this summary; full statistical reporting, sensitivity analyses, and secondary endpoint data require review of the complete manuscript. __BOTTOM_LINE_CATEGORY__ potentially_practice_informing __BOTTOM_LINE__ The LOGICAL trial — a large, pragmatic, assessor-blinded RCT across 53 ICUs — found no benefit of conservative oxygen therapy (SpO₂ 90–95%, FiO₂ titrated to 0.21) over liberal oxygen (no upper SpO₂ limit, minimum FiO₂ 0.30) for 180-day survival with favorable functional outcome in unresponsive, mechanically ventilated post-cardiac arrest patients (38.2% vs. 39.7%, p=0.65). This convincingly neutral result, consistent with the BOX and EXACT trials, does not support a strategy of aggressive oxygen restriction in ICU patients after cardiac arrest. Clinicians should continue avoiding frank hyperoxia per standard care principles, but a protocol-driven low-oxygen target strategy (FiO₂ to 0.21, SpO₂ cap at 95%) does not appear to confer additional neurological or survival benefit in this population.